EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic Insights into Anti-Nectin4-VcMMAE-Induced Ocular Toxicity: From Cellular Uptake Pathways to Molecular Modification

Jialing Zhang, Meng Li, Weiyu Li, Yuxuan Yang, Gang Wu, Peng Guo, Chuanfei Yu, Lan Wang

International Journal of Molecular Sciences · 22.05.2025 · 26 (11) · 4996

DOI: 10.3390/ijms26114996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.05.2025. Verfasst von Jialing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Monoclonal Antibodies, Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing 102629, China. Hauptthemen laut MEDLINE: Immunoconjugates, Antibodies, Monoclonal, Nectins, Cell Adhesion Molecules. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody–drug conjugates (ADCs) represent a novel approach to cancer treatment. Enfortumab vedotin (PADCEV), as a prominent example, has demonstrated remarkable clinical efficacy. However, its ocular toxicity has raised concerns. This study aimed to explore the molecular mechanisms underlying PADCEV—induced ocular toxicity. SD rats, whose ocular structures are similar to those of humans, were selected to establish an ocular toxicity model to mimic the human response. In vitro experiments were conducted using human primary corneal epithelial cells, HCE-T. The results confirmed that nectin-4 plays a crucial role in the cellular uptake of PADCEV, and non-specific pinocytosis is also involved. Additionally, a variant was obtained by introducing point mutations in the Fc region of PADCEV, which was found to reduce corneal epithelial toxicity. The findings of this study not only deepen our understanding of ADC-induced ocular toxicity but also provide new insights into optimizing ADC design and enhancing treatment safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesAntibodies, MonoclonalNectinsCell Adhesion MoleculesAnimalsHumansRatsRats, Sprague-DawleyEpithelial CellsEpithelium, CornealMale

Stichwörter der Autor:innen

endocytosis mechanismenfortumab vedotinmolecular optimizationocular toxicity

Substanzen

ImmunoconjugatesAntibodies, MonoclonalNectinsCell Adhesion Molecules

Autor:innen und Institutionen

  • Division of Monoclonal Antibodies, Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing 102629, China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 311121, China.
  • State Key Laboratory of Drug Regulatory Science, National Institutes for Food and Drug Control, Beijing 102629, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Zhang, J., Li, M., Li, W., Yang, Y., Wu, G., Guo, P., Yu, C., & Wang, L. (2025). Mechanistic Insights into Anti-Nectin4-VcMMAE-Induced Ocular Toxicity: From Cellular Uptake Pathways to Molecular Modification. International Journal of Molecular Sciences, 26(11), 4996. https://doi.org/10.3390/ijms26114996

Vancouver

Zhang J, Li M, Li W, Yang Y, Wu G, Guo P, et al. Mechanistic Insights into Anti-Nectin4-VcMMAE-Induced Ocular Toxicity: From Cellular Uptake Pathways to Molecular Modification. International Journal of Molecular Sciences. 2025;26(11):4996. doi:10.3390/ijms26114996

BibTeX
@article{Zhang2025,
  author = {Zhang, Jialing and Li, Meng and Li, Weiyu and Yang, Yuxuan and Wu, Gang and Guo, Peng and Yu, Chuanfei and Wang, Lan},
  title = {Mechanistic Insights into Anti-Nectin4-VcMMAE-Induced Ocular Toxicity: From Cellular Uptake Pathways to Molecular Modification},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {11},
  pages = {4996},
  doi = {10.3390/ijms26114996}
}
Kostenlos starten →